These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36305015)

  • 1. Meeting report: 34th international conference on antiviral research.
    Brancale A; Carter K; Delang L; Deval J; Durantel D; Gentry BG; Jordan R; Julander JG; Lo MK; Pérez-Pérez MJ; Schang LM; Seley-Radtke KL; Shi PY; Vasudevan SG; Whitley RJ; Spengler JR
    Antivir Chem Chemother; 2022; 30():20402066221130853. PubMed ID: 36305015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meeting report: 36th International Conference on Antiviral Research in Lyon, France - March 13-17, 2023.
    Spengler JR; Carter K; Delang L; Durantel D; Gowen BB; Herrero LJ; Hurst B; Janeba Z; Jordan R; Luo D; Meier C; Moffat J; Rocha-Pereira J; Seley-Radtke KL; Welch SR; Schang LM
    Antiviral Res; 2023 Sep; 217():105678. PubMed ID: 37494979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meeting report: 35th International Conference on Antiviral Research in Seattle, Washington, USA - March 21-25, 2022.
    Spengler JR; Welch SR; Deval J; Gentry BG; Brancale A; Carter K; Moffat J; Meier C; Seley-Radtke KL; Schang LM
    Antiviral Res; 2023 Mar; 211():105521. PubMed ID: 36596323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meeting report: 32nd International Conference on Antiviral Research.
    Tramontano E; Tarbet B; Spengler JR; Seley-Radtke K; Meier C; Jordan R; Janeba Z; Gowen B; Gentry B; Esté JA; Bray M; Andrei G; Schang LM;
    Antiviral Res; 2019 Sep; 169():104550. PubMed ID: 31302149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18th International Conference on Antiviral Research.
    Mitchell WM
    Expert Opin Pharmacother; 2005 Aug; 6(10):1765-8. PubMed ID: 16086663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development.
    Aljabali AAA; Bakshi HA; Satija S; Metha M; Prasher P; Ennab RM; Chellappan DK; Gupta G; Negi P; Goyal R; Sharma A; Mishra V; Dureja H; Dua K; Tambuwala MM
    Pharm Nanotechnol; 2020; 8(4):323-353. PubMed ID: 32811406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meeting report: 31
    Bray M; Andrei G; Ballana E; Carter K; Durantel D; Gentry B; Janeba Z; Moffat J; Oomen CJ; Tarbet B; Riveira-Muñoz E; Esté JA;
    Antiviral Res; 2018 Oct; 158():88-102. PubMed ID: 30086336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scientific report: highlights of 25th ICAR, 16-19 April 2012, Sapporo, Japan.
    Hodge AV
    Antivir Chem Chemother; 2012 Sep; 23(1):19-33. PubMed ID: 22976587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meeting report: 30th International Conference on Antiviral Research, in Atlanta, GA, USA.
    Vere Hodge RA
    Antivir Chem Chemother; 2018; 26():2040206618783924. PubMed ID: 29954186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.
    Abdurrahman L; Fang X; Zhang Y
    Curr Mol Med; 2022; 22(7):621-639. PubMed ID: 34645374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International society for antiviral research - 23rd international conference.
    Mason VL
    IDrugs; 2010 Jun; 13(6):363-5. PubMed ID: 20506054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highlights of the 30th International Conference on Antiviral Research.
    Andrei G; Carter K; Janeba Z; Sampath A; Schang LM; Tarbet EB; Vere Hodge RA; Bray M; Esté JA
    Antiviral Res; 2017 Sep; 145():184-196. PubMed ID: 28774800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral Efficacy of Molnupiravir for COVID-19 Treatment.
    Bai Y; Shen M; Zhang L
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Perspective of Antiviral Strategies against COVID-19.
    Ahidjo BA; Loe MWC; Ng YL; Mok CK; Chu JJH
    ACS Infect Dis; 2020 Jul; 6(7):1624-1634. PubMed ID: 32485102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metal-based complexes against SARS-CoV-2.
    Ioannou K; Vlasiou MC
    Biometals; 2022 Aug; 35(4):639-652. PubMed ID: 35332435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and Antiviral Properties against SARS-CoV-2 of Epoxybenzooxocino[4,3-
    Stalinskaya AL; Martynenko NV; Shulgau ZT; Shustov AV; Keyer VV; Kulakov IV
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19: Progress in diagnostics, therapy and vaccination.
    Liu X; Liu C; Liu G; Luo W; Xia N
    Theranostics; 2020; 10(17):7821-7835. PubMed ID: 32685022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovering small-molecule therapeutics against SARS-CoV-2.
    Tiwari V; Beer JC; Sankaranarayanan NV; Swanson-Mungerson M; Desai UR
    Drug Discov Today; 2020 Aug; 25(8):1535-1544. PubMed ID: 32574699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological insight into potential therapeutic agents for the deadly Covid-19 pandemic.
    Bhandari R; Khanna G; Kuhad A
    Eur J Pharmacol; 2021 Jan; 890():173643. PubMed ID: 33065092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
    Froggatt HM; Heaton BE; Heaton NS
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.